Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension

Published:2021-05 Issue: Volume:85 Page:111124
ISSN:0899-9007
Container-title:Nutrition
language:en
Short-container-title:Nutrition

Author:

King Susannah J.,Tierney Audrey C.,Edgeworth Deirdre,Keating Dominic,Williams Elyssa,Kotsimbos Tom,Button Brenda M.,Wilson John W.

Funder

Vertex Pharmaceuticals

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease;Barry;Chest,2014

2. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation;Davies;Am J Respir Crit Care Med,2013

3. Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: A phase 3, open-label extension study (PERSIST);McKone;Lancet Respir Med,2014

4. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

5. Improvement in exercise duration, lung function and well-being in G551D-cystic fibrosis patients: a double-blind, placebo-controlled, randomized, cross-over study with ivacaftor treatment;Edgeworth;Clin Sci (Lond),2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic modifiers of body mass index in individuals with cystic fibrosis;The American Journal of Human Genetics;2024-09

2. Nutritional status in the era of highly effective CFTR modulators;Pediatric Pulmonology;2024-08-06

3. Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: A follow-up study;Nutrition;2024-07

4. Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis;Scientific Reports;2024-04-24

5. ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis;Clinical Nutrition;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3